Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00215410 · ClinicalTrials.gov registry record · Phase 2

Study in Patients With Asthma

A Phase 2 study of Asthma, sponsored by Dey.

Completed
Registry status
Phase 2
Development phase
36
Enrollment target
12
Study locations

NCT00215410 is a Phase 2 study of Asthma that has completed, run by Dey. The registered enrollment target is 36 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 12 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00215410, a Phase 2 study of Asthma, has completed, sponsored by Dey.

COMPLETED
Registry status
Phase 2
Development phase
36 participants
Enrollment target
12
Study locations

Study Summary

The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.

Conditions Studied

Asthma

Interventions

  • DRUG Formoterol Fumarate

Study Locations (12)

California

  • Research Site - Long Beach
  • Research Site - Mission Viejo
  • Research Site - Newport Beach
  • Research Site - Orange
  • Research Site - Vista

Oregon

  • Research Site - Medford
  • Research Site - Portland

Texas

  • Research Site - Fort Worth
  • Research Site - Houston

Arkansas

  • Research Site - Little Rock

Colorado

  • Research Site - Englewood

Oklahoma

  • Research Site - Oklahoma City

Trial Details

FieldValue
Enrollment Target 36 participants
Est. Completion 2005-10
Phase Phase 2

Sponsor

Dey

21 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00215410

The ClinicalTrials.gov registry entry for NCT00215410 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is Dey, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Formoterol Fumarate is the first listed.

NCT00215410 reports 12 study locations spanning 6 distinct geographic areas - top geographies include California, Oregon, Texas.

Frequently Asked Questions

What is clinical trial NCT00215410 about?

NCT00215410 is a clinical study titled "Study in Patients With Asthma". The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.

What is the current status of trial NCT00215410?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. Estimated completion is 2005-10.

What conditions does trial NCT00215410 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00215410?

The interventions under investigation include: Formoterol Fumarate (DRUG).

Who is sponsoring clinical trial NCT00215410?

This trial is sponsored by Dey, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00215410 being conducted?

This trial has 12 study locations across Arkansas, California, Colorado, Oklahoma, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.